Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | 7HP349 |
Synonyms | |
Therapy Description |
7HP349 is a small molecule that activates VLA-4 (integrin alpha4beta1) and ITGB2 (LFA-1), potentially leading to enhanced antitumor immune response and inhibition of tumor growth (PMID: 35552271). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
7HP349 | alintegimod|7HP 349|7HP-349 | 7HP349 is a small molecule that activates VLA-4 (integrin alpha4beta1) and ITGB2 (LFA-1), potentially leading to enhanced antitumor immune response and inhibition of tumor growth (PMID: 35552271). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|